Trial
NCT02620761
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Patent Ductus Arteriosus (PDA)
Intervention
Fenoldopam
Why stopped
Inability to recruit patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-16